A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Global Distribution of Human Protoparvoviruses
Tekijät: Elina Väisänen, Ushanandini Mohanraj, Paula M. Kinnunen1, Pikka Jokelainen, Haider Al-Hello, Ali M. Barakat, Mohammadreza Sadeghi, Farid A. Jalilian, Amir Majlesi, Moses Masika, Dufton Mwaengo, Omu Anzala, Eric Delwart, Olli Vapalahti, Klaus Hedman, Maria Söderlund-Venermo
Kustantaja: CENTERS DISEASE CONTROL
Julkaisuvuosi: 2018
Journal: Emerging Infectious Diseases
Tietokannassa oleva lehden nimi: EMERGING INFECTIOUS DISEASES
Lehden akronyymi: EMERG INFECT DIS
Vuosikerta: 24
Numero: 7
Aloitussivu: 1292
Lopetussivu: 1299
Sivujen määrä: 8
ISSN: 1080-6040
DOI: https://doi.org/10.3201/eid2407.172128
Verkko-osoite: https://wwwnc.cdc.gov/eid/article/24/7/17-2128_article
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/32503927
Development of next-generation sequencing and metagenomics has revolutionized detection of novel viruses. Among these viruses are 3 human protoparvoviruses: bufavirus, tusavirus, and cutavirus. These viruses have been detected in feces of children with diarrhea. In addition, cutavirus has been detected in skin biopsy specimens of cutaneous T-cell lymphoma patients in France and in 1 melanoma patient in Denmark. We studied seroprevalences of IgG against bufavirus, tusavirus, and cutavirus in various populations (n = 840), and found a striking geographic difference in prevalence of bufavirus IgG. Although prevalence was low in adult populations in Finland (1.9%) and the United States (3.6%), bufavirus IgG was highly prevalent in populations in Iraq (84.8%), Iran (56.1%), and Kenya (72.3%). Conversely, cutavirus IgG showed evenly low prevalences (0%-5.6%) in all cohorts, and tusavirus IgG was not detected. These results provide new insights on the global distribution and endemic areas of protoparvoviruses.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
